India-based Leucine Rich Bio, South Asia’s pioneering microbiome company, has announced a distribution partnership with Trinature Wellness in Malaysia to introduce its flagship gut microbiome test, BugSpeaks, to the Malaysian market. This collaboration marks another milestone in Leucine Rich Bio’s global expansion, bringing its innovative health solutions to Southeast Asia.
BugSpeaks, a non-invasive, at-home gut microbiome test, leverages advanced next-generation sequencing and proprietary algorithms to provide personalised insights into gut health.
The test offers a detailed analysis of microbial composition, a unique disease susceptibility index, and tailored dietary and supplement recommendations. Its credibility is underscored by a clinical trial publication in PeerJ (an internationally peer-reviewed scientific journal), showcasing its success in improving clinical outcomes for hyperglycemia patients through microbiome-based diets. BugSpeaks is backed by Leucine Rich Bio’s ISO 9001:2015 and ISO 17025:2017 certifications, along with NABH accreditation, ensuring unparalleled quality and trust.
This partnership builds on Leucine Rich Bio’s robust global footprint, with successful collaborations including Cognoa International Inc. in the Philippines, Medsol Diagnostics in the UAE, and distributors in Thailand and Brazil. These efforts have cemented BugSpeaks as a cornerstone of preventive healthcare, serving over 15,000 customers worldwide.
The collaboration with Trinature Wellness promises to elevate Malaysia’s wellness ecosystem by offering a groundbreaking tool to optimise gut health and drive personalised healthcare forward. Leucine Rich Bio remains at the forefront of microbiome innovation, reshaping the future of well-being globally.
